Follow
Arman Romiani
Arman Romiani
PhD Student, University of Gothenburg
Verified email at gu.se
Title
Cited by
Cited by
Year
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
EFA A Romiani, J Spetz, E Shubbar, D E Lind, B Hallberg, R H Palmer
BMC cancer 21 (1), 1-14, 2021
82021
Synergistic Antitumor Effects of 177Lu-Octreotide Combined with an ALK Inhibitor in a High-Risk Neuroblastoma Xenograft Model
A Romiani, D Pettersson, N Rassol, K Simonsson, H Bakr, DE Lind, ...
Preprints, 2024
2024
Förbättrad radionuklidterapi av neuroblastom
A Romiani
2023
Improved Radionuclide Therapy of Neuroblastoma: Preclinical Evaluation of 177Lu-labeled Somatostatin Analogs
A Romiani
Department of Medical Radiation Sciences, Institute of Clinical Sciences …, 2023
2023
Better therapeutic results after fractionated administration of 177Lu-octreotate in mice bearing human neuroblastoma
A Romiani, J Spetz, B Hallberg, R Palmer, E Forssell-Aronsson
EANM'18, 2018
2018
Small scale dosimetry for 211At distribution in thyroid and liver models using AlfaMC Monte Carlo simulations
A Romiani
The system can't perform the operation now. Try again later.
Articles 1–6